Eton Pharmaceuticals Inc. (ETON)
50.19
+0.97 (1.97%)
Upcoming Events
Latest Headlines
Form 8-K Eton Pharmaceuticals, For: Oct 14
October 14, 2026 7:15 AM - SEC Filing
Eton and Aquestive strike U.S. deal for diazepam buccal film
October 14, 2026 6:51 AM - StreetInsider
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
October 14, 2026 6:50 AM - StreetInsider
Form 4 Eton Pharmaceuticals, For: Oct 06 Filed by: Krempa David
October 6, 2026 4:49 PM - SEC Filing
Form 144 Eton Pharmaceuticals, Filed by: Krempa David
October 6, 2026 4:05 PM - SEC Filing
Form 8-K Eton Pharmaceuticals, For: Sep 28
September 28, 2026 7:15 AM - SEC Filing
Eton Pharmaceuticals launches Impavido capsules in the U.S.
September 28, 2026 6:51 AM - StreetInsider
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
September 28, 2026 6:50 AM - StreetInsider
Form 4 Eton Pharmaceuticals, For: Aug 28 Filed by: MAIER PAUL V
August 28, 2026 4:51 PM - SEC Filing
Form 144 Eton Pharmaceuticals, Filed by: MAIER PAUL V
August 28, 2026 4:41 PM - SEC Filing
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
August 27, 2026 6:50 AM - StreetInsider
Form 4 Eton Pharmaceuticals, For: Aug 24 Filed by: Krempa David
August 24, 2026 5:20 PM - SEC Filing
Form 144 Eton Pharmaceuticals, Filed by: Krempa David
August 24, 2026 4:20 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Aug 19 Filed by: BRYNJELSEN SEAN
August 20, 2026 6:26 PM - SEC Filing
Form 144/A Eton Pharmaceuticals, Filed by: BRYNJELSEN SEAN
August 20, 2026 5:01 PM - SEC Filing
Form 144 Eton Pharmaceuticals, Filed by: BRYNJELSEN SEAN
August 19, 2026 10:50 AM - SEC Filing
Eton Pharmaceuticals (ETON) PT Raised to $70 at B.Riley
August 14, 2026 8:29 AM - StreetInsider
Eton Pharmaceuticals (ETON) PT Raised to $70 at H.C. Wainwright
August 14, 2026 6:49 AM - StreetInsider
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
August 13, 2026 4:30 PM - StreetInsider
Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
August 13, 2026 4:18 PM - StreetInsider
Form 10-Q Eton Pharmaceuticals, For: Jun 30
August 13, 2026 4:18 PM - SEC Filing
Form 8-K Eton Pharmaceuticals, For: Aug 13
August 13, 2026 4:13 PM - SEC Filing
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 13, 2026 4:05 PM - StreetInsider
Form 3 Eton Pharmaceuticals, For: Jul 31 Filed by: Radosavljevic Danka
August 12, 2026 5:01 PM - SEC Filing
Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
August 11, 2026 6:51 AM - StreetInsider
Form 8-K Eton Pharmaceuticals, For: Jul 31
August 5, 2026 7:00 AM - SEC Filing
Eton Pharmaceuticals licenses topical gel ASN-001 for infantile hemangiomas
August 5, 2026 6:50 AM - StreetInsider
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 5, 2026 6:50 AM - StreetInsider
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: CASAMENTO CHARLES J
August 4, 2026 5:11 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: Matthews Judith M.
August 4, 2026 5:05 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: Erdogan-Trinkaus Ipek
August 4, 2026 5:03 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: BRYNJELSEN SEAN
August 4, 2026 5:02 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: Krempa David
August 4, 2026 5:01 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: MAIER PAUL V
August 4, 2026 4:57 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: RIEDEL NORBERT G
August 4, 2026 4:57 PM - SEC Filing
Form 4 Eton Pharmaceuticals, For: Jul 31 Filed by: Adams Jennifer McKie
August 4, 2026 4:55 PM - SEC Filing
Form 8-K Eton Pharmaceuticals, For: Jul 31
August 4, 2026 7:00 AM - SEC Filing
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
August 3, 2026 6:50 AM - StreetInsider
Form 8-K Eton Pharmaceuticals, For: Jul 29
July 29, 2026 7:00 AM - SEC Filing
Eton Pharmaceuticals files FDA supplement to expand Khindivi to under-5s
July 29, 2026 6:50 AM - StreetInsider
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
July 29, 2026 6:50 AM - StreetInsider
Form SCHEDULE 13G/A Eton Pharmaceuticals, Filed by: BlackRock, Inc.
July 28, 2026 4:45 PM - SEC Filing
Full Article List